1、Costbenefit analysis for synthetic nucleic acid screening in the European UnionFor more information on this publication,visit www.rand.org/t/RRA4805-1This research was funded through income from operations and philanthropic donations from RAND supporters,including a generous gift from Sentinel Bio.A
2、bout RAND Europe RAND Europe is a not-for-profit research organisation that helps improve policy and decision making through research and analysis.To learn more about RAND Europe,visit www.randeurope.org.Research Integrity Our mission to help improve policy and decision making through research and a
3、nalysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behaviour.To help ensure our research and analysis are rigorous,objective,and nonpartisan,we subject our research publications to a robust and exacting qu
4、ality-assurance process;avoid both the appearance and reality of financial and other conflicts of interest through staff training,project screening,and a policy of mandatory disclosure;and pursue transparency in our research engagements through our commitment to the open publication of our research
5、findings and recommendations,disclosure of the source of funding of published research,and policies to ensure intellectual independence.For more information,visit www.rand.org/about/research-integrity.RANDs publications do not necessarily reflect the opinions of its research clients and sponsors.Pub
6、lished by the RAND Corporation,Santa Monica,Calif.,and Cambridge,UK 2026 RAND CorporationR is a registered trademark.Cover:Adobe StockLimited Print and Electronic Distribution Rights This publication and trademark(s)contained herein are protected by law.This representation of RAND intellectual prope